Drug Approval | July 24, 2022
Dr. Reddy's announces the first-to-market, OTC launch of Allegra-D in the US market
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
PM congratulates citizens on crossing the 200 crore milestone of Covid vaccination drive
The approval has been accorded by IFCI Limited for manufacturing of the product "7 ACA"
Manish led SeQuent since 2014 and played a major role in transforming the company
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
Upgrades and global expansion provide additional control, visibility, reliability and recovery for patient-critical, time-and temperature-sensitive products
The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
Plant is part of the company's CAD $30 million capital investment in the site
LifeWell Raises USD 80M from OrbiMed to Build Large Scale Healthcare Delivery Platform with Full stack Diagnostics~
Subscribe To Our Newsletter & Stay Updated
